Medical Condition News

RSS

Novel gene-based therapies for sickle cell disease rely on finding the right mouse for the job

Sickle cell disease is an extremely debilitating condition that affects up to 40% of the population in African countries, with patients suffering episodes of excruciating pain, organ damage and reduced life-expectancy.

7 Jul 2022

Gestures can help to get the message across for people with language disorders

When words fail, gestures can help to get the message across - especially for people who have a language disorder. An international research team has now shown that listeners attend the gestures of people with aphasia more often and for much longer than previously thought. This has implications for the use of gestures in speech therapy.

7 Jul 2022

COVID-19 was the third leading cause of death in the US in 2020 and 2021

In a recent article published in the journal JAMA Internal Medicine, investigators examined the major causes of mortality across the United States (US) in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

7 Jul 2022

COVID-19 and brain damage explained

In a recent study published in the Brain journal, researchers in the United States analyzed the neurovascular injury in coronavirus disease 2019 (COVID-19).

7 Jul 2022

2022 monkeypox presents with new symptoms

In a recent study published in The Lancet Infectious Diseases, researchers described the clinical and demographical characteristics of monkeypox virus infections among individuals attending sexual health centers in the United Kingdom (UK).

6 Jul 2022

COVID-19 impairs the insulin/IGF signaling pathway

Scientists evaluate the impact of SARS-CoV-2 on the insulin/IGF signaling pathway.

6 Jul 2022

The role of myostatin in female fertility

A new study discusses some of the key functions of myostatin in female reproductive health and disease.

6 Jul 2022

DZNE and Intravacc receive € 2.5 million EU funding to develop a prototype ALS vaccine

DZNE and Intravacc B.V., a world leading contract development and manufacturing organization (CDMO) of preventive and therapeutic vaccines, have been awarded a funding of € 2.5 million from the European Union (EIC Transition Grant) to further develop a prototype ALS vaccine, including process development, scale-up, and toxicology study.

6 Jul 2022

Damon Runyon Cancer Research Foundation names five new Damon Runyon Clinical Investigators

The Damon Runyon Cancer Research Foundation has named five new Damon Runyon Clinical Investigators.

6 Jul 2022

Bereavement linked to increased risk of death in heart failure patients

Heart failure patients experiencing grief or in mourning following the loss of a close family member are at an increased risk of death, particularly during the first week following the family member's death, according to a study published today in JACC: Heart Failure.

6 Jul 2022

Noradrenergic drugs could be repurposed to offer effective treatment for Alzheimer's disease symptoms

There is "good evidence" that drugs to treat attention deficit hyperactivity disorder (ADHD) might also successfully treat key aspects of Alzheimer's disease, finds a pooled data analysis of the available research, published online in the Journal of Neurology Neurosurgery & Psychiatry.

6 Jul 2022

Scientists discover a key starting point for inhibiting inflammation in psoriasis and psoriatic arthritis

Around 250,000 people in Austria suffer from psoriasis. One third of them develop inflammation in their joints (psoriatic arthritis) as a result of the chronic skin condition.

6 Jul 2022

Outpatient antibiotic management of patients with appendicitis is safe, helps avoid surgery

Outpatient antibiotic management of selected patients with appendicitis is safe, allowing many patients to avoid surgery and hospitalization, and should be considered as part of shared decision-making between doctor and patient.

6 Jul 2022

Genetically engineered kidney organoids solve mystery of a rare disease

Researchers have solved a medical mystery in a poorly understood disease by uncovering which cells cause tumors in patients with tuberous sclerosis complex (TSC).

6 Jul 2022

‘Hypervitaminosis D’ is on the rise and linked to serious health issues

'Overdosing' on vitamin D supplements is both possible and harmful, warn doctors in the journal BMJ Case Reports after they treated a man who needed hospital admission for his excessive vitamin D intake.

6 Jul 2022

Study measures changes in the brain's response to threat following non-invasive vagus nerve stimulation

A first-of-its-kind study published recently in the journal "Brain Stimulation" measures changes in the human brain's response to a perceived threat following non-invasive stimulation of the nervous system via the vagus nerve

6 Jul 2022

Bone marrow transplants may be an effective treatment for ALS, research suggests

Along with the central nervous system, the immune system may play a fundamental role in Amyotrophic Lateral Sclerosis (ALS), suggesting that bone marrow transplants may be an effective novel treatment for the neurodegenerative disease.

6 Jul 2022

Healthy, cancer, and immunosuppressed patients all benefit from COVID boosters

In a recent study posted to the medRxiv* pre-print server, researchers developed a mechanistic mathematical model to predict the course of vaccine-induced immunity in healthy and immunosuppressed patients for the long term, exceeding the time frames for which clinical data is currently available.

5 Jul 2022

What role does human microbiota play in COVID-19 severity?

In a recent study published in the journal Advanced Science, researchers explored the dynamic changes in the respiratory tract and gut microbiota in coronavirus disease 2019 (COVID-19) patients. They observed and analyzed these changes during different disease progression stages among patients with differential disease severities.

5 Jul 2022

What causes insomnia and how to treat it?

A new study evaluates the symptoms of insomnia and its treatment as reported by patients in primary care settings.

5 Jul 2022

Medical Condition News

Novel gene-based therapies for sickle cell disease rely on finding the right mouse for the job

Gestures can help to get the message across for people with language disorders

COVID-19 was the third leading cause of death in the US in 2020 and 2021

COVID-19 and brain damage explained

2022 monkeypox presents with new symptoms

COVID-19 impairs the insulin/IGF signaling pathway

The role of myostatin in female fertility

DZNE and Intravacc receive € 2.5 million EU funding to develop a prototype ALS vaccine

Damon Runyon Cancer Research Foundation names five new Damon Runyon Clinical Investigators

Bereavement linked to increased risk of death in heart failure patients

Noradrenergic drugs could be repurposed to offer effective treatment for Alzheimer's disease symptoms

Scientists discover a key starting point for inhibiting inflammation in psoriasis and psoriatic arthritis

Outpatient antibiotic management of patients with appendicitis is safe, helps avoid surgery

Genetically engineered kidney organoids solve mystery of a rare disease

‘Hypervitaminosis D’ is on the rise and linked to serious health issues

Study measures changes in the brain's response to threat following non-invasive vagus nerve stimulation

Bone marrow transplants may be an effective treatment for ALS, research suggests

Healthy, cancer, and immunosuppressed patients all benefit from COVID boosters

What role does human microbiota play in COVID-19 severity?

What causes insomnia and how to treat it?

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News